Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, indicating a new version of the page. This typically accompanies minor content or metadata updates rather than changes to the trial data.
    Difference
    0.1%
    Check dated 2026-07-04T04:46:43.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision tag changed to v3.6.2, indicating a minor maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-06-27T02:52:55.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Recruitment status is updated to indicate no new enrollments for this study. The update also adds a few navigation/label changes and a revision note (v3.6.0), including new sections like 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' while standardizing the 'Intervention/Treatment' heading.
    Difference
    0.4%
    Check dated 2026-06-12T16:19:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows a new revision label, v3.5.5, replacing the prior v3.5.4. This indicates a different published version of the page, likely an administrative update rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:12.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page footer now shows revision v3.5.4 instead of v3.5.3. This signals an update to the site's documentation version rather than any study details.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:15.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The study record revision was incremented from v3.5.2 to v3.5.3, replacing the previous revision. This indicates a minor update to the record or its documents.
    Difference
    0.1%
    Check dated 2026-04-30T16:26:54.000Z thumbnail image

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.